An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases	Cerebral Small Vessel Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Granuloma, Hemic and Lymphatic Diseases, IgA glomerulonephritis, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, eosinophilic granulomatosis with polyangiitis, glomerulonephritis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, kidney disorder, lung disorder, lupus nephritis, lymphatic system disorder, lymphoproliferative syndrome, membranous glomerulonephritis, microscopic polyangiitis, necrotizing vasculitis, nephritis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, urinary system disorder, vascular disorder, vasculitis	Active, not recruiting	Phase 1 / Phase 2	2025-10-14		NCT05732402

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alpine Immune Sciences, Inc.	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Johns Hopkins University School of Medicine	Baltimore	United States	1
Washington University School of Medicine in St. Louis	St Louis	United States	31